Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Relapses of Plasmodium vivax malaria threaten disease elimination

Time to deploy tafenoquine in India

Dados Bibliográficos

ID21879006
AutoresSundus Shafat Ahmad (0000-0002-4008-2544, National Institute of Malaria Research), Manju Rahi (0000-0003-0932-0935, Indian Council of Medical Research), Amit Sharma (0000-0001-6130-1913, National Institute of Malaria Research, autor correspondente)
Ano2021
Volume6
Fascículo2
Páginase004558
Data de publicação2021-02-01
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoBMJ Global Health (JOURNAL)
Identificadores do periódicoISSN: 2059-7908 • E-ISSN: 2059-7908
EditoraBMJ (PUBLISHER • GB)
DOI10.1136/bmjgh-2020-004558
PMID33619041
OpenAlexW3130380135
IdiomaEN
Citações recebidas4
Referências citadas22

Millions suffer from the scourge of malaria across the world, reflected by the estimated 228 million cases and 0.4 million deaths it caused in 2018, as reported in the World Malaria Report 2019. India and African nations shouldered 85% of the world’s malaria burden in 2018. The South-East Asia Region recorded a 70% decrease in malaria incidence from 2010 (17 cases/1000 population) to 2018 (5 cases/1000 population). Despite the absolute reduction in India’s malaria cases, with 2.6 million fewer cases in 2018 than in 2017, India’s malaria burden still remains considerable at an estimated 6.7 million cases.1 Out of all the global Plasmodium vivax burden, 53% is in the WHO South-East Asia Region, India accounting for 47% and is a major cause of health burden in these countries.1 P. vivax malaria is now known to cause considerable morbidity and mortality due to severe malaria.2 In addition, due to relapses P. vivax causes additional burden on disease burden and feeds transmission. Despite the problem of P. vivax , malaria control have hitherto focused more on P. falciparum . It is likely that this burden will increase in 2020–2021 due to diversion of public health attention towards COVID-19. At the same time, there is a potential for several cross-learnings between malaria and COVID-19.3 4 Nonetheless, P. vivax continues to

Disease · Disease burden · Environmental health · Malaria · Plasmodium falciparum · Plasmodium vivax · Population · Public health · Malaria Research and Control · Medicine · Mosquito-borne diseases and control · Travel-related health issues · Immunology · Internal Medicine

  • Tracking district-level performance in the context of achieving zero indigenous case status by 2027

    Open Access•Chander Prakash Yadav, Syed Shah Areeb Hussain et al.•PLOS Global Public Health•2023

  • Vivax malaria

    Open Access•Ashwani Kumar, Puspendra Pal Singh et al.•Frontiers in Public Health•2024

  • Four decades of epidemiological data reveal trajectories towards malaria elimination in Kheda district (Gujarat), western part of India

    Open Access•Rajendra Kumar Baharia, Chander Prakash Yadav et al.•BMJ Global Health•2021

  • What India can learn from globally successful malaria elimination programmes

    Open Access•Delia Dumitrescu, Sachin Sharma et al.•BMJ Global Health•2022

Obras citantes distintas4
Citações por ano0,8
Intervalo de citações2021 - 2024 (4)
Velocidade de citaçãorecent
Altamente citadoNão
Tipos de citaçãoNeutras: 3
Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae